Literature DB >> 304692

[Prevention and treatment of upper gastrointestinal haemorrhage with cimetidine and somatostatin in intensiv care patients (author's transl)].

H Bauer, A Doenicke, F Holle.   

Abstract

Upper gastrointestinal haemorrhage is a severe problem in patients in surgical intensive care units. Good experimental and clinical results are reported with somatostatin (somatotropin release inhibitoring factor) and cimetidine (H2-receptor antagonist) in prevention and treatment of acute gastrointestinal bleeding, by blocking gastric acid secretion. These experiences are confirmed with an open trial in 13 seriously ill surgical patients. First of all cimetidine can be recommended because of its mode of action and application.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 304692

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  3 in total

1.  Histamine and stress ulcer: new components in organizing a sequential trial on cimetidine prophylaxis in seriously ill patients and definition of a special group at risk (severe polytrauma).

Authors:  W Lorenz; M Fischer; H Rohde; H Troidl; H J Reimann; C Ohmann
Journal:  Klin Wochenschr       Date:  1980-07-01

2.  [Secretin versus somatostatin in acute hemorrhage of gastroduodenal ulcers and erosions: a randomized trial].

Authors:  P K Wagner; M Rothmund; J Grönniger
Journal:  Klin Wochenschr       Date:  1983-03-15

Review 3.  Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units.

Authors:  Ingrid Toews; Aneesh Thomas George; John V Peter; Richard Kirubakaran; Luís Eduardo S Fontes; Jabez Paul Barnabas Ezekiel; Joerg J Meerpohl
Journal:  Cochrane Database Syst Rev       Date:  2018-06-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.